Variable | Estimate (quotient) | Standard error | 95% Confidence limits | P value ANOVA/RMANOVA | P value for normality (Shapiro-Wilk) | |
---|---|---|---|---|---|---|
Lower | Upper | |||||
Primary endpoint | ||||||
1/Modified GCPS score (without B) | 1.12 | 0.08 | 0.97* | 1.29 | 0.12 | <.0001** |
1/Unmodified GCPS score (with B) | 1.13 | 0.09 | 0.96* | 1.32 | 0.13 | 0.0005** |
Secondary endpoints | ||||||
1/Pain at rest | 1.19 | 0.16 | 0.91* | 1.55 | 0.20 | <.0001** |
1/Pain at palpation/manipulation | 1.18 | 0.18 | 0.87* | 1.58 | 0.28 | 0.0049** |
1/Global efficacy score | 1.08 | 0.07 | 0.94* | 1.23 | 0.28 | <.0001** |
1/Global inflammation score | 1.31 | 0.23 | 0.93* | 1.85 | 0.12 | 0.058 |
1/Owner assessment: demeanor | 1.00 | 0.02 | 0.95* | 1.05 | 0.96 | 0.010** |
1/Owner assessment: mobility | 0.95 | 0.03 | 0.89* | 1.02 | 0.17 | 0.010** |